<?xml version="1.0" encoding="UTF-8"?>
<p>When unusually high incidence of a clinical syndrome is observed in a group of patients (a cluster), there may be suspicion of a shared infection, which could constitute an outbreak. Initial investigation must therefore identify what pathogen is present in order to confirm an outbreak and kick-start a response. The first cluster of patients with COVID-19 was identified on December 21, 2019, after which investigations were carried out by the Chinese Center for Disease Control and Prevention and the National Institute of Viral Disease Control and Prevention [
 <xref rid="ppat.1008902.ref007" ref-type="bibr">7</xref>,
 <xref rid="ppat.1008902.ref008" ref-type="bibr">8</xref>]. A diagnostic panel covering 22 human pathogens was run on these patients, with universally negative results [
 <xref rid="ppat.1008902.ref008" ref-type="bibr">8</xref>]. This immediately raised suspicion of a novel pathogen, requiring discovery methods.
</p>
